Navigation Links
Doctors Outraged Over Growth Hormone Controversy

Two anti-aging preventative medicine doctors say they are outraged over recent media coverage about their advocacy of prescribing human growth hormone to treat a hormone deficiency often associated with aging.

DAYTONA BEACH, Fla., April 27, 2007 /PRNewswire/ -- The adult use of human growth hormone (HGH) was at the center of a recent New York Times article about the founders of the American Academy of Anti-Aging Medicine (, Dr. Ronald Klatz M.D. and Dr. Robert Goldman M.D.

Writing for the New York Times, Duff Wilson reported the two physicians to be promoting the controversial hormone as an aid to extending human life span, despite claimed reports of serious side effects.

In comments to Fintan Dunne, editor of health Web site, the two physicians say they are outraged by a slew of recent negative media coverage on the topic. has a special report with an in-depth examination of the HGH issue and the role of established medical and pharmaceutical interests.

"There is a hidden battle going on for your right to a long, vital and healthy life," says Editor, Fintan Dunne. "Beneath the surface of this story there are hundreds of billions of dollars at stake, along with the future of medicine itself."

Dunne reports that the nascent promise of the anti-aging movement, spearheaded by the American Academy of Anti-Aging Medicine, is to greatly enhance our health as we age. However, he says that is also the worst nightmare of a pharmaceutical industry bent on easing us into premature death with a plethora of profitably expensive medications. "Viewed by entrenched medical interests, the burgeoning development of anti-aging medicine is a potent threat," says Dunne.

The special report on asks:

Is HGH real ly a dangerous drug, or a proven and safe treatment for adult growth hormone deficiency?

What lies behind the New York Times' reporting on these anti-aging preventative medicine surgeons?

Is the public being subjected to a campaign designed to discredit the field of anti-aging medicine?

Read the full story:

"True Lies About Anti-Aging and Growth Hormone"

CONTACT: Fintan Dunne (Ireland) of, +353-85-732-8141,

Web site:

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
2. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
4. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
5. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference
9. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
10. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
11. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Italian therapeutic drug monitoring ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm of ... obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer ... 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified that on ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... ... November 25, 2015 , ... Castlewood Treatment Center ... with eating disorders as a result of the $20,000 raised at the center’s ... Fox Run Golf Club in Eureka, will help individuals who otherwise might not ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development ... expansion of its current state of the art research, development and manufacturing facility ... increase its manufacturing capacity as well as to support its clients’ growing research ...
Breaking Medicine News(10 mins):